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Abstract
The ability of a New World (NW) clade B arenavirus to enter cells using human transferrin receptor 1 (TfR1) strictly correlates
with its ability to cause hemorrhagic fever. Amapari (AMAV) and Tacaribe (TCRV), two nonpathogenic NW clade B
arenaviruses that do not use human TfR1, are closely related to the NW arenaviruses that cause hemorrhagic fevers. Here we
show that pseudotyped viruses bearing the surface glycoprotein (GP) of AMAV or TCRV can infect cells using the TfR1
orthologs of several mammalian species, including those of their respective natural hosts, the small rodent Neacomys
spinosus and the fruit bat Artibeus jamaicensis. Mutation of one residue in human TfR1 makes it a functional receptor for
TCRV, and mutation of four residues makes it a functional receptor for AMAV. Our data support an in vivo role for TfR1 in the
replication of most, if not all, NW clade B arenaviruses, and suggest that with modest changes in their GPs the
nonpathogenic arenaviruses could use human TfR1 and emerge as human pathogens.
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Introduction
Arenaviruses are enveloped viruses that carry single-stranded,
bi-segmented, RNA genomes [1]. The family Arenaviridae compris-
es a single genus (Arenavirus) that contains at least 25 members
[2–4]. Arenaviruses have been classified into two antigenically and
geographically distinct groups, the Lassa-lymphocytic choriomen-
ingitis serocomplex (‘‘Old World arenaviruses’’) and the Tacaribe
serocomplex (‘‘New World arenaviruses’’) [5–7]. The New World
(NW) arenavirus cluster is subdivided into clades A, B, and C. In
addition, several North American viruses are recombination
products of clades A and B (A/B) (Figure 1). All NW arenaviruses
that cause hemorrhagic fever in humans are in the B clade. These
include the Junı ´n (JUNV), Machupo (MACV), Guanarito
(GTOV), and Sabia ´ (SABV) viruses, which respectively cause
Argentine, Bolivian, Venezuelan, and Brazilian hemorrhagic
fevers with high (10–30%) case fatality rates [2,8,9]. A novel
NW clade B arenavirus, Chapare virus, was recently isolated from
a fatal case of hemorrhagic fever in Bolivia [3].
In addition to these pathogens, there are clade B viruses that do
not cause disease in humans. These include the Amapari (AMAV),
Cupixi (CPXV), and Tacaribe (TCRV) viruses, although TCRV
may have caused a febrile illness with mild central nervous system
symptoms in a laboratory worker [10]. Pathogenic and nonpatho-
genic NW arenaviruses do not cluster independently on phyloge-
netic analysis; TCRV is closely related to MACV and JUNV,
while AMAV shares highest sequence similarity with GTOV
(Figure 1).
The zoonotic reservoir of a given NW arenavirus has a unique
geographical distribution, and each arenavirus prefers its own host
[11]. Most of the natural hosts for NW arenaviruses belong to the
subfamily Sigmodontinae in the family Cricetidae, which contains
NW mice and rats [6,12]. The host animals for MACV, JUNV
and GTOV are Calomys callosus (large vesper mouse), Calomys
musculinus (drylands vesper mouse), and Zygodontomys brevicauda
(short-tailed cane mouse), respectively [13–16]. The natural
reservoirs of SABV and Chapare virus have not been identified.
AMAV was isolated from Neacomys spinosus (bristly mouse) and
Neacomys guianea (Guiana bristly mouse), and TCRV is suggested to
have a non-rodent host, Artibeus species fruit bats in Trinidad and
Tobago [12,17–19].
The arenavirus envelope glycoprotein (GP), the sole protein
found on the surface of virions, is processed into three associated
subunits: the stable signal peptide (SSP), GP1, and GP2 [20,21].
SSP is a unique component of the arenaviral fusion machinery and
plays a role in the transport, maturation, and pH dependent
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subunit engages a cellular receptor(s), and GP2 mediates pH-
dependent membrane fusion after viral particles are internalized
into acidified endosomes [21,26–29].
Two cell surface molecules have been implicated as cellular
receptors for arenaviruses. Old World arenaviruses and NW clade
C arenaviruses Oliveros and Latino use a-dystroglycan as an
obligate receptor, while the pathogenic NW clade B arenaviruses
MACV, JUNV, GTOV and SABV use human transferrin
receptor 1 (TfR1) to infect cells [30–33]. The ability of NW clade
B arenaviruses to cause disease in humans correlates with the
utilization of human TfR1, a molecule that has several properties
favorable to arenaviral replication and viral hemorrhagic fevers; it
is rapidly endocytosed into acidic compartments, expressed on
endothelial cells, and upregulated on rapidly dividing cells
including activated lymphocytes [34–38]. We have previously
shown that recombinant retroviral particles pseudotyped with the
GPs of MACV, JUNV, or GTOV efficiently use the TfR1
ortholog of the rodent hosts of these viruses [39].
A number of studies have suggested that AMAV and TCRV do
not use human TfR1 [40–43]. Blocking human cells with
inactivated AMAV significantly reduces the infection of these
cells with AMAV pseudovirus, but does not interfere with the
infection of MACV, JUNV or GTOV pseudoviruses [43]. It
remains to be shown, however, if these nonpathogenic NW
arenaviruses could use the TfR1 orthologs of their principal host
animals. Here, we confirm that AMAV and TCRV do not use
human TfR1, and show that they nonetheless efficiently use the
TfR1 orthologs of their respective animal hosts, N. spinosus and A.
jamaicensis. We also show that mutation of one residue converts
human TfR1 into an efficient receptor for TCRV, and
replacement of four residues with those found in N. spinosus
TfR1 converts human TfR1 into an efficient receptor for AMAV.
These data show that TfR1 has an important role in the
replication of nonpathogenic NW arenaviruses, and suggest that
subtle changes in the GPs of TCRV and AMAV might adapt them
to use human TfR1.
Results
AMAV and TCRV pseudoviruses do not use human TfR1
We confirmed that human TfR1 is not involved in the entry of
AMAV and TCRV into human cells by examining whether an a-
human TfR1 antibody could inhibit the infection of HEK293T
cells mediated by the GPs of AMAV and TCRV. We generated
recombinant Moloney murine leukemia virus (MLV) expressing
green-fluorescent protein (GFP), pseudotyped with the GPs of
AMAV, TCRV, MACV and GTOV. Cells were exposed to these
recombinant viruses in the presence or absence of a control
antibody (a-HLA), or an a-human TfR1 antibody previously
shown to inhibit infection of MACV and JUNV pseudoviruses
[32]. Infection levels were assayed forty-eight hours later by flow
cytometry (Figure 2). The a-human TfR1 antibody inhibited
infection by GTOV and MACV pseudoviruses, but had no effect
on the entry of AMAV and TCRV pseudoviruses. The entry of all
four pseudoviruses was unaffected by the a-HLA antibody. These
results are in agreement with previous studies showing that human
TfR1 is not involved in the entry of the nonpathogenic NW clade
B arenaviruses into human cells [40].
Animal orthologs of TfR1 support entry of AMAV and
TCRV pseudoviruses
Phylogenetic analysis reveals that GTOV GP shares greater
sequence similarity with AMAV GP than it does with the GPs of
the other pathogenic NW arenaviruses (Figure 1). AMAV,
however, does not use human TfR1 as a cellular receptor. We
sought to determine if animal orthologs of TfR1 could support
entry mediated by the GPs of AMAV and TCRV. Chinese
hamster ovary (CHO) cells were transfected with plasmids
expressing the human, mouse, rat, feline, canine, Calomys callosus
(Cc ; MACV host), Calomys musculinus (Cm ; JUNV host), or
Figure 1. Phylogeny of New World arenaviruses based on GP
sequences. All known clade B viruses are included, whereas only
representative examples of other clades are shown. The sequences used
in the analysis are those of full-length GPs: ALLV, Allpahuayo virus;
AMAV, Amapari virus; BCNV, Bear Canyon virus; Catarina virus; Chapare
virus; CPXV, Cupixi virus; FLEV, Flexal virus; GTOV, Guanarito virus; JUNV,
Junı ´n virus; LATV, Latino virus; MACV, Machupo virus; OLVV, Oliveros
virus; PARV, Parana ´ virus; PICV, Pichinde ´ virus; PIRV, Pirital virus; SABV,
Sabia ´ virus; Skinner Tank virus; TCRV, Tacaribe virus; TAMV, Tamiami
virus; WWAV, Whitewater Arroyo virus. The GenBank accession numbers
of these viruses are indicated in the Materials and Methods section.
Viruses that cause hemorrhagic fever in humans, which are only found
in clade B (encircled), are labeled with an asterisk. Viruses known to use
human TfR1 are boxed in orange, and the nonpathogenic arenaviruses
investigated in this study are boxed in cyan [39,40].
doi:10.1371/journal.ppat.1000358.g001
Author Summary
Several arenaviruses found in the New World cause
hemorrhagic fever when they are transmitted from their
natural reservoirs to humans. These pathogenic arenavi-
ruses use human transferrin receptor 1 (TfR1), a protein
involved in cellular iron uptake, to infect human cells. The
nonpathogenic New World arenaviruses characterized thus
far do not use human TfR1. We show here that two of
these nonpathogenic viruses, Amapari and Tacaribe, can
use animal orthologs of TfR1 to infect cells. We observe
that recombinant viruses coated with the entry proteins of
Amapari and Tacaribe viruses use the TfR1 orthologs of
their natural reservoirs. Modest alteration of human TfR1
converts it to an efficient receptor for Amapari and
Tacaribe viruses. Our findings provide insight into the
potential of Amapari and Tacaribe viruses to adapt to use
human TfR1 and perhaps emerge as human pathogens.
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expression was assessed by flow cytometry using an antibody
directed against a flag tag added to the C-terminus of each
ortholog. In parallel, aliquots of the same cells were infected with
AMAV or TCRV pseudoviruses. As these viruses readily enter
CHO cells using a TfR1-independent pathway, pseudoviruses
were diluted to minimize background entry. Pseudovirus bearing
the GP of lymphocytic choriomeningitis virus (LCMV) was used as
a control. As shown in Figure 3A, infection by AMAV and TCRV
pseudoviruses was significantly enhanced by the introduction of
ZbTfR1 into CHO cells, while AMAV pseudovirus entry was
enhanced to a lesser degree by CcTfR1. The entry of AMAV
pseudovirus was also enhanced by feline TfR1 expression. We and
others have previously shown that this TfR1 ortholog is also used
efficiently by the pathogenic viruses MACV, JUNV and GTOV
[39,40]. The entry of LCMV pseudovirus was unaffected. We
repeated these experiments using HEK293T cells, and obtained
similar results (Figure 3B). These data show that although AMAV
and TCRV pseudoviruses do not use human TfR1, they
nonetheless use the TfR1 orthologs of several mammalian species.
AMAV and TCRV bind and use the TfR1 orthologs of their
host animals
We next investigated whether AMAV and TCRV GP could
also use the TfR1 orthologs of their host species, the small rodent
N. spinosus and the fruit bat A. jamaicensis, respectively. We cloned
the genes of their TfR1 orthologs by RT-PCR from frozen tissues
of N. spinosus (NsTfR1) and A. jamaicensis (AjTfR1). In order to
determine the ability of the AMAV and TCRV GP1 proteins to
bind these TfR1 orthologs, HEK293T cells were transfected with
plasmids expressing human, Ns, or AjTfR1. These cells were
incubated with Ig-fusion proteins comprising the GP1 subunits of
AMAV or TCRV (AMAV-GP1D-Ig and TCRV-GP1D-Ig,
respectively). The binding of these proteins to transfected cells
was measured by flow cytometry using an a-human IgG antibody.
The expression levels of TfR1 orthologs were assessed in parallel
using an a-flag antibody. As shown in Figure 4A, while the
expression levels of all TfR1 orthologs were comparable (left
panels), AMAV-GP1D-Ig bound cells expressing NsTfR1, but did
not bind cells expressing AjTfR1. TCRV-GP1D-Ig bound cells
expressing AjTfR1 and also cells expressing NsTfR1. Neither Ig-
fusion protein bound cells expressing human TfR1. Although both
AMAV and TCRV pseudoviruses enter HEK293T cells using a
TfR1-independent pathway, indicating the presence of an
alternative receptor, we did not observe binding of AMAV or
TCRV-GP1D-Ig to these cells (data not shown). This observation
is consistent with an entry process dependent on a lower affinity
receptor.
To determine if AMAV and TCRV pseudoviruses could use
NsTfR1 and AjTfR1 to infect cells, HEK293T cells were
transfected with plasmids expressing human TfR1, ZbTfR1,
NsTfR1, AjTfR1, or vector alone, and then incubated with
AMAV and TCRV pseudoviruses. Pseudovirus bearing the G
protein of vesicular stomatitis virus (VSV) was used as a control.
Consistent with the GP1D-Ig binding data, AMAV pseudovirus
used only NsTfR1, while TCRV pseudovirus efficiently used both
AjTfR1 and NsTfR1 (Figure 4B). We next assessed whether
NsTfR1 and AjTfR1 could also serve as receptors for the
pathogenic NW clade B arenaviruses. As the pathogenic NW
arenaviruses efficiently enter HEK293T cells using endogenous
human TfR1 [32], CHO cells were transfected with plasmids
expressing human TfR1, AjTfR1, NsTfR1, ZbTfR1, or vector
alone, and subsequently infected with MACV, JUNV, or GTOV
pseudoviruses. As shown in Figure 4C, MACV and JUNV, like
TCRV, used both NsTfR1 and AjTfR1, while GTOV, like the
closely related AMAV, efficiently used NsTfR1 but not AjTfR1.
We confirmed these findings using replication-competent
TCRV and AMAV viruses. HEK293 cells were transfected with
plasmids expressing human TfR1, AjTfR1 or NsTfR1, and
subsequently infected with replication-competent TCRV or
AMAV. As shown in Figure 5, the infection of TCRV was
enhanced on cells expressing AjTfR1 and NsTfR1, while that of
AMAV was only enhanced on cells expressing NsTfR1.
Modest changes convert human TfR1 into an efficient
receptor for nonpathogenic NW arenaviruses
A loop (residues 202–212) between b strands 1 and 2 in the
apical domain of human TfR1 is a likely interaction site for the
GPs of the NW hemorrhagic fever arenaviruses [39,44]. This loop
includes tyrosine 211, which is essential for MACV, JUNV, and
GTOV to use human TfR1 [39]. We compared the sequences of
ZbTfR1, NsTfR1, and AjTfR1 in this region with that of human
TfR1, and found several differences between human and animal
TfR1 (Figure 6A and 6B). We sought to determine whether
replacing the human TfR1 residues with their equivalents from
animal TfR1 orthologs would allow the modified human TfR1 to
serve as a receptor for AMAV and TCRV pseudoviruses.
Figure 6A shows a panel of eleven human TfR1 variants that
were examined. In the first two variants (zh1 and zh2), residues
from human TfR1 were replaced with those from ZbTfR1. Four
variants (ah2 through ah5) include residues from AjTfR1, and five
variants (nh2, nh4, nh5, nh7 and nh8) include NsTfR1 sequence.
These variants were expressed in HEK293T cells, and the cells
were incubated with TCRV or AMAV pseudoviruses. A variant
(zh1) containing two alterations - R208G and DV210 - was an
efficient receptor for TCRV (Figure 6C). As expected from
comparison with zh1, a variant (ah2) containing three AjTfR1
residues in place of human TfR1 residues 208–210 (R208G,
L209A, and V210G) was a functional receptor for TCRV
(Figure 6D). When mutations at R208 and V210 were individually
introduced into human TfR1, the variant containing V210G (ah4)
supported TCRV pseudovirus entry efficiently, while the variant
containing R208G (ah3) was a less efficient receptor. Deletion of
V210 (ah5), however, did not convert human TfR1 into a receptor
for TCRV. A slightly larger alteration in human TfR1 was
Figure 2. AMAV and TCRV pseudovirus entry does not depend
on human TfR1. HEK293T cells were infected with GTOV, AMAV, TCRV,
or MACV pseudoviruses expressing GFP in the presence or absence of
the indicated concentrations of an a-human TfR1 (BD Pharmingen) or a
control (a-HLA) antibody (BD Pharmingen). Infection levels were
assessed 48 hr later by measuring GFP expression by flow cytometry.
Mean fluorescence values were normalized to that of cells infected in
the absence of antibody. GFP mean fluorescence values for virus entry
in the absence of antibody were 144.0, 89.7, 92.3, and 115.0 for GTOV,
AMAV, TCRV, and MACV, respectively.
doi:10.1371/journal.ppat.1000358.g002
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four mutations - D204N, K205S, R208G, and DV210 - or nh8,
which contains five mutations, were efficient receptors for AMAV
(Figure 6E). The entry of VSV pseudovirus was unaffected by the
introduction of any of the variants. Thus, only minimal alteration
of human TfR1 was sufficient for it to serve as an efficient receptor
for the nonpathogenic viruses AMAV and TCRV.
Discussion
Five NW arenaviruses have been shown to cause hemorrhagic
fever in humans. We have previously shown that four of these
viruses – MACV, JUNV, GTOV, and SABV – require TfR1 to
enter human cells [32]. We have also shown that these viruses
utilize the TfR1 orthologs of their rodent hosts efficiently and with
specificity [39]. A recently identified fifth hemorrhagic fever NW
arenavirus, Chapare virus, remains to be characterized. Collec-
tively, these data indicate a central role for TfR1 in the replication
of NW clade B arenaviruses that cause hemorrhagic fever in
humans.
Closely related to these pathogenic viruses are three clade B
arenaviruses that do not cause disease in humans, namely TCRV,
AMAV, and CPXV, although TCRV may have caused mild
disease in a laboratory worker [10]. Here we have studied the two
best characterized of these viruses, TCRV and AMAV. The GP
sequences of these viruses are more similar to those of the
pathogenic viruses than they are to each other (Figure 1). In spite
of the similarity of AMAV and TCRV to the other members of
their respective subclades, these nonpathogenic viruses do not
utilize human TfR1. In contrast, every clade B virus shown to use
Figure 3. AMAV and TCRV pseudoviruses can use animal orthologs of TfR1. CHO cells ((A), left panel) were transfected with vector alone
(mock) or plasmids encoding human, mouse, rat, feline, canine, C. callosus (Cc), C. musculinus (Cm), and Z. brevicauda (Zb) TfR1 orthologs. HEK293T
cells ((B), right panel) were transfected with the same plasmids with the exception of the one encoding canine TfR1. Cell surface expression was
determined 48 hr later by flow cytometry using an antibody directed against a flag tag present at the C-terminus of each ortholog. In parallel,
aliquots of these cells were infected with AMAV, TCRV, or LCMV pseudoviruses. Infection levels were assessed as in Figure 2. Expression levels of
various TfR1 were normalized to that of human TfR1 (a-flag, top panels). Infection levels were normalized to that of mock-transfected cells.
doi:10.1371/journal.ppat.1000358.g003
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PLoS Pathogens | www.plospathogens.org 4 April 2009 | Volume 5 | Issue 4 | e1000358Figure 4. AMAV and TCRV GPs bind and use the TfR1 orthologs of their respective host species. (A) HEK293T cells were transfected with
plasmids encoding human TfR1 (hTfR1), N. spinosus TfR1 (NsTfR1), or A. jamaicensis TfR1 (AjTfR1). Cells were incubated 48 hr later with an a-flag
antibody or Ig-fusion proteins comprising the truncated GP1 subunits [32] of AMAV and TCRV (AMAV GP1D-Ig and TCRV GP1D-Ig, respectively). The
association of these proteins with cells was measured by flow cytometry. The data shown are representative of two independent experiments,
duplicated in each assay, with similar results. Mean fluorescence values for TfR1 ortholog expression were 435, 380, and 458 for human, Ns, and
AjTfR1, respectively. Mean fluorescence values for AMAV GP1D-Ig binding to transfected cells were 1.5, 597, and 1.6, and those for TCRV GPD-Ig
binding were 3.7, 425, and 553 for human, Ns, and AjTfR1, respectively. (B) HEK293T cells were transfected with plasmids encoding human, ZbTfR1,
NsTfR1, AjTfR1 orthologs or vector alone. Cell surface expression of the TfR1 orthologs was determined as in Figure 3. Aliquots of these cells were
infected with AMAV, TCRV, or VSV pseudoviruses, and infection levels were assessed as in Figure 2. (C) An experiment similar to the one performed in
(B), except CHO cells were used for transfection and infected with MACV, JUNV, GTOV, or VSV pseudoviruses. Expression levels of the various TfR1
orthologs were normalized to that of human TfR1 (a-flag, left panels). Infection levels were normalized to that of mock-transfected cells.
doi:10.1371/journal.ppat.1000358.g004
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35]. There is thus a close correlation between use of human TfR1
and the ability of a NW arenavirus to cause severe human disease.
A possible exception is the Whitewater Arroyo virus (WWAV), a
NW clade A/B arenavirus that does not appear to use human
TfR1, but is tentatively associated with three human fatalities in
1999–2000 [45,46]. Follow up studies by the CDC, however,
failed to find any evidence of WWAV infection in the human
tissues mentioned in the original article (Nichol, personal
communication). In addition, there have been no further reports
of WWAV infection being associated with human disease.
This correlation suggests that TfR1 use is a key determinant in
the virulence of clade B viruses, which raises an important
question: how easily might clade B viruses circulating in animals
gain the ability to use human TfR1? Our findings shed light on
this issue; TCRV and AMAV pseudoviruses efficiently utilize the
TfR1 orthologs of several species including those of their native
hosts, A. jamaicensis and N. spinosus, respectively (Figures 3 and 4).
As with the pathogenic clade B viruses, AMAV and TCRV
utilized most efficiently the TfR1 ortholog of their natural hosts. It
is therefore likely that TfR1 is also central to the replication of
these nonpathogenic viruses in their native hosts.
To investigate the possibility that gain-of-use of human TfR1
may not require extensive alteration of the TCRV and AMAV
GPs, we sought to identify differences between human TfR1 and
host animal TfR1 orthologs that determine the ability of these
molecules to support infection by TCRV and AMAV pseudo-
viruses. We swapped residues in a loop in the apical domain of
TfR1 that is a key determinant of host specificity (Figure 6).
Surprisingly, alteration of a single residue (V210G, ah4) allowed
human TfR1 to efficiently support the entry of TCRV
pseudovirus, while replacement of four residues in this loop with
the corresponding residues of NsTfR1 (nh5) was necessary to
support efficient infection by AMAV pseudovirus (Figure 6D and
6E). Although these alterations are made to the receptor, it is
reasonable to infer that similarly modest changes in the arenaviral
GPs would also permit efficient use of human TfR1. For example,
in order to bind human TfR1, TCRV GP would only need to
acquire mutations that accommodate V210, present in human
TfR1 but absent or replaced by a glycine in animal TfR1
orthologs. Our data, although limited, suggest that small
alterations in the arenaviral GP could convert these nonpatho-
genic NW arenaviruses into human pathogens.
This possibility has precedent in other emerging viruses. For
example, alteration of only a few residues in the spike protein of
the severe acute respiratory syndrome coronavirus (SARS-CoV)
was sufficient for this glycoprotein, derived from an animal isolate
of the virus, to efficiently use the human ortholog of its receptor,
angiotensin converting enzyme 2 (ACE2) [47]. Similarly, the
adaptation of avian influenza viruses to humans is thought to
require as few as two amino acid substitutions in the influenza
hemagglutinin glycoprotein (HA). These mutations allow HA to
bind its human receptor, a2,6 -linked sialosides [48,49]. Structural
studies of the SARS-CoV and influenza A virus entry proteins in
complex with their respective receptors have helped to identify
and predict entry protein alterations that contribute to the ability
of these viruses to cause human disease [48,50]. Similar studies of
arenanaviral GP molecules bound to TfR1 are likely to further
elucidate the risk posed by AMAV, TCRV, and perhaps other
nonpathogenic arenaviruses.
Of note in this regard, bats are increasingly recognized as
reservoirs for viruses that can cross species barriers to infect
humans [51]. Nipah, Hendra, and perhaps SARS-CoV and Ebola
viruses, are on the list of emerging viruses that involve
amplification in bat hosts [52]. Although TCRV was isolated
from bats [19], the suggestion that Artibeus species bats serve as
the natural hosts for TCRV has been questioned [53]. Our
observation that AjTfR1 is an efficient receptor for TCRV, and
also for JUNV and MACV, supports a role for bats in sustaining
the replication of arenaviruses. Ecological surveys of bats for novel
arenaviruses are thus warranted, and may afford further insight
into the diversity of arenaviruses. In addition, although cats
experimentally infected with MACV do not become ill [54], viral
titers in these animals were not determined. The finding that feline
TfR1 supports the entry of AMAV and the pathogenic clade B
arenaviruses thus highlights a possible role for cats in serving as
intermediate hosts in the transmission of NW arenaviruses to
humans [39,40].
Despite the inability of AMAV and TCRV to cause disease in
humans, their GP proteins mediate entry into human cells through
a pathway independent of human TfR1 or a-dystroglycan
(Figure 2) [40,43]. This observation suggests that these viruses
Figure 5. Host-animal orthologs of TfR1 support the entry of infectious AMAV and TCRV. HEK293 cells were transfected with plasmids
encoding human TfR1, AjTfR1, or NsTfR1, and infectious viruses added at 36 hr post-transfection. Incubation was continued for 12 hr, and the cells
were washed, fixed, and stained as described in Materials and Methods.
doi:10.1371/journal.ppat.1000358.g005
Nonpathogenic NW Arenaviruses Use TfR1
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pathogenic clade B arenaviruses may also use an additional
receptor [40]. Indeed, certain strains of the Old World arenavirus
lymphocytic choriomeningitis virus (LCMV) use both a-dystrogly-
can dependent and independent pathways to infect cells [55]. An
alternative receptor may substitute for TfR1, or function
downstream of TfR1 in a manner analogous to the HIV-1
coreceptors. Identification of such a receptor on human cells will
likely broaden our understanding of the entry mechanisms of a
number of NW arenaviruses.
Materials and Methods
Phylogeny
ClustalW was used to align the GP sequences of the NW
arenaviruses and for phylogenetic calculations, and the cladogram
was plotted using Drawtree [56,57]. The sequences used in the
analysis are those of full-length GPs: ALLV, Allpahuayo virus
(strain CHLP 2472, GenBank accession no. AY012687); AMAV,
Amapari virus (BeAn 70563, AF512834); BCNV, Bear Canyon
virus (A0060209, AF512833); Catarina virus (AV A0400212,
DQ865245); Chapare virus (810419, EU260463); CPXV, Cupixi
virus (BeAn 119303, AF512832); FLEV, Flexal virus (BeAn
HEK293922, AF512831); GTOV, Guanarito virus (strain INH
95551, NC_005077); JUNV, Junı ´n virus (MC2, D10072); LATV,
Latino virus (MARU 10924, AF512830); MACV, Machupo virus
(Carvallo, NC_005078); OLVV, Oliveros virus (3229 1, U34248);
PARV, Parana ´ virus (12056, AF512829); PICV, Pichinde ´ virus
(AN3739, NC_006447); PIRV, Pirital virus (VAV 488,
AF277659); SABV, Sabia ´ virus (SPH114202, NC_006317);
Skinner Tank virus (AV D1000090, EU123328); TCRV, Tacaribe
virus (TRVL 11573, NC_004HEK293); TAMV, Tamiami virus
(W 10777, AF512828); WWAV, Whitewater Arroyo virus (AV
9310135, AF228063).
Cells and plasmids
HEK293T cells (human embryonic kidney, ATCC, CRL-
11268) were maintained in Dulbecco’s modified Eagle’s medium,
and CHO cells (Chinese hamster ovary epithelial, ATCC, CCL-
61) in F12 medium. Both cell lines were grown in the presence of
10% fetal bovine serum. Plasmids encoding human, mouse, rat, C.
callosus (large vesper mouse), and C. musculinus (drylands vesper
mouse), Z. brevicauda (short-tailed cane mouse) TfR1 are previously
described [39]. The plasmids expressing the TfR1 orthologs of F.
domesticus (cat) and C. familiaris (dog) were generously provided by
Colin Parrish (Cornell University, Ithaca, NY). TfR1 genes for
Neacomys spinosus and Artibeus jamaicensis were cloned from frozen
heart and kidney, and liver tissues, respectively. Deposited
sequences in GenBank (FJ154604 and FJ154605) cross-reference
to catalog numbers of the Museum of Southwestern Biology,
University of New Mexico from where these specimens were
obtained. RNA was isolated from these tissues using RNAqueous
(Ambion), and cDNA was generated by SuperScript III First-
Strand Synthesis system for RT-PCR (Invitrogen). PCR primers
used to amplify the genes for both NsTfR1 or AjTfR1 ortho-
logs are: sense 59 ATGATGGATCAAGCCAGATCAGCAWT-
CTCT 39 and anti-sense 59 AAAYTCATTGTCAATGTCC-
CAAAYGTCACCA 39. These genes, fused with a C-terminal flag
tag, were cloned into the pcDNA3.1 expression vector (Invitro-
gen). Amino acid substitutions in human TfR1 were performed
using the QuikChange method for site-directed mutagenesis
(Stratagene).
AMAV GP1D-Ig and TCRV GP1D-Ig were generated by
PCR-amplification of AMAV GP1 residues 80–228 and TCRV
GP1 residues 87–243, with boundary residues selected according
to a similar construct of MACV GP1 previously shown to bind
most efficiently to Vero cells [32]. These fragments were cloned
into a previously described pcDM8-based plasmid containing the
CD5 signal sequence and the Fc region of human IgG1 [58].
MACV (Carvallo strain), JUNV (MC2), and GTOV (INH-95551),
GP-expressor plasmids have been described previously [32].
Genes for AMAV and TCRV GP are gifts from Stefan Kunz
(University of Lausanne, Switzerland); they were PCR amplified
from infected Vero cells, and cloned into pCAGGS expression
vector. The sequence of AMAV GP is the same as BeAn 7063
strain (GenBank AF512834), and that of TCRV has a deletion
spanning amino acid residues 121–132, and substitutions at three
residues, I134A, G418S and E458R, compared to GenBank
NC_004293.
GP1D-Ig binding assays
AMAV GP1D-Ig and TCRV GP1D-Ig binding to various TfR1
orthologs was detected by flow cytometry. Ig-fusion proteins were
produced in Free Style HEK293 Expression Medium (Invitrogen)
from HEK293T cells transfected with the appropriate plasmid,
purified by binding to protein-A Sepharose and eluted with 3 M
MgCl2, dialyzed in PBS, and concentrated using a YM50 filter
unit (Millipore). For binding assays, HEK293T cells were
transfected with the various TfR1-encoding plasmids. After
48 hr, cells were detached by 1 mM EDTA/PBS and incubated
in 100 ul of PBS-2% goat serum containing 0.5 ug of either an a-
flag M2 monoclonal antibody (Sigma) or the indicated Ig-fusion
protein. Cells were then stained with a-mouse IgG, or with a-
human IgG (Fc-specific) antibodies conjugated with phycoerythrin
(Jackson Immuno Laboratories), respectively.
Pseudovirus infection
To generate recombinant retroviruses pseudotyped with
arenaviral GP molecules, HEK293T cells were transfected at a
1:1:1 ratio with plasmids encoding the respective arenaviral GP,
the MLV gag and pol genes, and the pQCXIX retroviral vector
(BD Biosciences) expressing GFP, as previously described [32].
Figure 6. Modest mutations convert human TfR1 into an efficient receptor for AMAV and TCRV. (A) The structure of the human TfR1
dimer is shown, oriented with the cell membrane at the bottom. The apical, protease-like, and helical domains are indicated in green, red, and yellow,
respectively, on one monomer. The other monomer is shown in cyan. In the right panel, the TfR1 apical domain is enlarged; a loop comprising
residues 202-212, implicated as a site of interaction with the GPs of NW clade B arenaviruses, is shown. The side chains of residues D204, K205, R208,
V210, and Y211 are colored yellow. The image was rendered using PyMol [59]. (B) Sequence alignment of residues 195 through 216 of human TfR1
with analogous sequences of the TfR1 orthologs of Z. brevicauda (ZbTfR1), A. jamaicensis (AjTfR1), and N. spinosus (NsTfR1). Variants of human TfR1
containing sequence from Z. brevicauda (zh1 and zh2), A. jamaicensis (ah2 through ah5), and N. spinosus (nh2, nh4, nh5, nh7, and nh8) TfR1 were
generated based on this sequence alignment. Zb, Aj, and NsTfR1 sequences are shown in green, blue, and yellow, respectively. The right panel
summarizes the entry data. ND=not determined. (C–E) HEK293T cells were transfected with plasmids encoding human, Zb, Aj, or NsTfR1 along with
the zh variants (C), the ah variants (D), or the nh variants (E). The expression level of each TfR1 variant was assessed as in Figure 3. In parallel, cells
were infected with AMAV, TCRV, or VSV pseudoviruses. The expression levels of the various TfR1 orthologs were normalized to that of human TfR1 (a-
flag, left panels), and infection levels were normalized to that of mock-transfected cells.
doi:10.1371/journal.ppat.1000358.g006
Nonpathogenic NW Arenaviruses Use TfR1
PLoS Pathogens | www.plospathogens.org 8 April 2009 | Volume 5 | Issue 4 | e1000358Cell supernatants were harvested 24 hr post-transfection, and
filtered through a 0.45 mm filter. HEK293T cells or CHO cells
were transfected with plasmids expressing various TfR1 orthologs,
and at 24 hr, the cells were replated for flow cytometry and
infection. At 48 hr post-transfection, TfR1 expression levels were
assessed by flow cytometry using an a-flag M2 antibody. In
parallel, cells were infected with the indicated pseudoviruses for
2 hours. Twenty-four (HEK293T cells) or forty-eight (CHO cells)
hours after infection, the cells were detached with trypsin and the
GFP expression levels were measured by flow cytometry, and
normalized to that of mock-transfected cells. Values are the
average of 2–5 duplicated experiments.
Infection of live arenaviruses
Infection of HEK293 cells with replication-competent TCRV
(TRVL11573) or AMAV (BeAn70563), was performed in the
BSL3 laboratory at the Special Pathogens Branch, Centers for
Disease Control and Prevention, Atlanta. Infections and immu-
nofluorescence staining were performed as described previously
[32]. Briefly, HEK293 cells growing on gelatin-treated glass
coverslips were transfected with plasmids encoding AjTfR1,
NsTfR1, or human TfR1. Thirty-six hours later, these cells were
infected with TCRV or AMAV at a multiplicity of infection of 2.0.
At 12 hr post-infection, the cells were washed, fixed with 3%
formaldehyde, permeabilized with 0.1% Triton X-100 and
incubated with mouse hyperimmune sera specific for NW
arenaviruses. Cells were then washed and incubated with a
FITC-conjugated secondary antibody.
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